SEC Company Response from Neurotrope, Inc. (CIK 0001513856) — Apr 22, 2020

Neurotrope, Inc. (CIK 0001513856)
Date: April 22, 2020 · CIK: 0001513856 · Accession: 0001104659-20-049672

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-237745

Date

April 22, 2020

Author

Not clearly detected

Form

CORRESP

Company

Neurotrope, Inc. (CIK 0001513856)

Letter

VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Attention: Paul Fischer RE: Neurotrope, Inc. Registration Statement on Form S-3 File No. 333-237745 Acceleration Request

Dear Mr. Fischer:

With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Neurotrope, Inc. (the “Company”), that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Registration Statement to Friday, April 24, 2020, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.

The cooperation of the staff in meeting the timetable described above is very much appreciated.

Please call Jeffrey Schultz of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (212) 692-6732 with any comments or questions regarding the Registration Statement.

Very truly yours,
Neurotrope, Inc.

Show Raw Text

CORRESP
1
filename1.htm

Neurotrope, Inc.

1185 Avenue of the Americas, 3rd Floor

New York, New York 10036

    April 22, 2020

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Paul Fischer

 RE: Neurotrope, Inc.

Registration Statement on Form S-3

File No. 333-237745

Acceleration Request

Dear Mr. Fischer:

With respect to the
above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of Regulation
C promulgated under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Neurotrope,
Inc. (the “Company”), that the Securities and Exchange Commission (the “Commission”) accelerate the effective
date of the Registration Statement to Friday, April 24, 2020, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.

The cooperation of
the staff in meeting the timetable described above is very much appreciated.

Please call Jeffrey
Schultz of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (212) 692-6732 with any comments or
questions regarding the Registration Statement.

    Very truly yours,

    Neurotrope, Inc.

    /s/ Robert Weinstein

    By:  Robert Weinstein

    Its:  Chief Financial Officer

 cc: Jeffrey Schultz, Esq., Mintz, Levin, Cohn, Ferris,
Glovsky and Popeo, P.C.

SecProbe.io